Particle.news

Wearable Microneedle Patch Tracks Cardiac Troponin Continuously

Sampling interstitial fluid with painless microneedles, the patch tracks low-level cardiac troponin to help detect silent post-surgical heart injury.

Overview

  • Researchers led by Leyla Soleymani reported in Science Advances that they built a minimally invasive wearable—called the Differential Aptalyzer—embedding antibody- and aptamer-functionalized electrodes in hydrogel microneedles to measure cardiac troponin I (cTnI) continuously.
  • The team says the device achieved a clinically relevant sensitivity range for cTnI of 0.003 to 0.640 ng/mL and produced dose-dependent rise-and-fall signals in mice that matched serial blood immunoassays.
  • In mouse studies the patch detected naturally elevated cTnI in a coronary artery disease model, showing the platform can register endogenous heart-injury signals rather than only injected markers.
  • The sensing approach pairs high-affinity antibodies for selective protein capture with reversible aptamer electrochemical transduction so the sensor can operate reagentlessly over several days without repeated blood draws.
  • The researchers have CIHR funding for further testing and are advancing commercialization through startup Aptec Health, with human clinical validation and regulatory clearance listed as the next steps before clinical use.